Latest Cancer treatments Stories
AUSTIN, Texas, Jan.
DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5s2nhx/drug_delivery_in) has announced the addition a new report
A University of Colorado Cancer Center study published today in the International Journal of Radiation Oncology Biology and Physics shows that patients taking crizotinib for ALK+ non-small cell lung cancer may safely and durably use up to three courses of targeted radiation therapy to eradicate pockets of drug-resistant disease.
Dr. Marnix Bosch To Describe DCVax-Direct Technology And Program BETHESDA, Md., Jan. 27, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
Trial to evaluate ID-G100 in patients with Merkel cell carcinoma SEATTLE and SOUTH SAN FRANCISCO, Calif., Jan.
Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective.
Use of a twice-daily pill could turn a deadly blood cancer into a highly treatable disease.
In response to an article published by CBS Philly, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, elaborates on a new, cap-like device that helps
A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer.
Enables physicians and patients to proactively avoid toxicities from treatments unlikely to provide benefit SAN FRANCISCO, Jan.16, 2014 /PRNewswire/ -- Castle Biosciences today announced
- Emitting flashes of light; glittering.
More Images (3 images) »